The Covid-19 pandemic has infected millions of people across the world and caused several thousands of deaths. Given advances in extracorporeal life suppirt technology, ECMO for Covid-19 ARDS has proven to be successful in sustaining life, however has left a significant number of patients fully dependen on devices and incapable of beaing weaned. Lung transplantation, as a well-established therapy for end-stage lung disease, has been considered for some patients with Covid-19 ARD in the absence of lung recovery and the presence of findings suggestive of end-stage lung disease

International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome / T.N. Machuca, A. Bharat, C. Kurihara, R.G. Jr, S. Kim, A. Manerikar, A. Pelaez, M. Pipkin, A. Shahmohammadi, M. Rackauskas, S. Kg, K. Balakrishnan, A. Jindal, L. Schaheen, S. Hashimi, B. Bhuddhdev, A. Arjuna, L. Rosso, A. Palleschi, C. Lang, P. Jaksch, M. Nosotti, K. Hoetzenecker. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - 40:4(2021 Apr), pp. S12-S12. ((Intervento presentato al convegno The ISHLT2021 Annual Meeting & Scientific Sessions nel 2021.

International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome

L. Rosso;A. Palleschi;M. Nosotti
Penultimo
;
2021-04

Abstract

The Covid-19 pandemic has infected millions of people across the world and caused several thousands of deaths. Given advances in extracorporeal life suppirt technology, ECMO for Covid-19 ARDS has proven to be successful in sustaining life, however has left a significant number of patients fully dependen on devices and incapable of beaing weaned. Lung transplantation, as a well-established therapy for end-stage lung disease, has been considered for some patients with Covid-19 ARD in the absence of lung recovery and the presence of findings suggestive of end-stage lung disease
Settore MED/21 - Chirurgia Toracica
Article (author)
File in questo prodotto:
File Dimensione Formato  
ISHLT 2021 International Experience with Lung Tx for COVID-19... PUBBLICATO.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 2.72 MB
Formato Adobe PDF
2.72 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/858884
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact